Compare SID & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SID | BHC |
|---|---|---|
| Founded | 1941 | N/A |
| Country | Brazil | Canada |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2002 | 1996 |
| Metric | SID | BHC |
|---|---|---|
| Price | $1.43 | $5.40 |
| Analyst Decision | Strong Sell | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $1.40 | ★ $8.33 |
| AVG Volume (30 Days) | ★ 4.8M | 2.5M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $5.02 | $4.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.24 | $4.28 |
| 52 Week High | $2.20 | $8.69 |
| Indicator | SID | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 33.15 |
| Support Level | $1.35 | N/A |
| Resistance Level | $1.64 | $7.22 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 20.27 | 20.76 |
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.